Protalix BioTherapeutics (DE) Insider Trades
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $101.36K
- Sales
- 0 · $0
- Shares bought / sold
- 56.00K / 0
- Net activity
- Net buying $101,360
Protalix BioTherapeutics (DE) insider activity
Over the last 12 months, Protalix BioTherapeutics (DE) insiders reported 1 transaction on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $101,360 and sold $0 worth of stock, for net insider buying of $101,360. The most recent filing shows Bashan Dror (PRESIDENT AND CEO) buying 56,000 shares at $1.81 on Dec 19, 2025.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PLX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 19, 2025 | Bashan DrorPRESIDENT AND CEO | Buy | 56,000 | $101.36K | Form 4 |
| Nov 18, 2025 | Bar-Shalev AmosDirector | Sale | 168 | $314.16 | Form 4 |
| Sep 3, 2025 | Naos YaronSr. VP, Operations | Award | 25,000 | — | Form 4 |
| Sep 3, 2025 | Bar-Shalev AmosDirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Forster EliotDirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Bashan DrorPRESIDENT AND CEO | Award | 195,000 | — | Form 4 |
| Sep 3, 2025 | Ben Zvi ShmuelDirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Schwartz AharonDirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Melincoff Gwen ADirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Elze ChristianDirector | Award | 7,500 | — | Form 4 |
| Sep 3, 2025 | Boudes Pol FDirector | Award | 7,500 | — | Form 4 |
| Jun 10, 2025 | Schwartz AharonDirector | Buy | 129,000 | $205.88K | Form 4 |
| Sep 23, 2024 | Rubin EyalSr. VP and CFO | Award | 99,010 | — | Form 4 |
| Sep 23, 2024 | Rubin EyalSr. VP and CFO | Award | 90,909 | — | Form 4 |
| Apr 1, 2024 | Bashan DrorPRESIDENT AND CEO | Award | 263,960 | — | Form 4 |
| Oct 19, 2023 | Bashan DrorPRESIDENT AND CEO | Buy | 16,129 | $22.74K | Form 4 |
| Oct 19, 2023 | Bashan DrorPRESIDENT AND CEO | Buy | 48,387 | $67.74K | Form 4 |
| Aug 15, 2023 | Bashan DrorPresident and CEO | Award | 800,000 | — | Form 4 |
| Aug 15, 2023 | Naos YaronSr. VP, Operations | Award | 187,344 | — | Form 4 |
| Aug 15, 2023 | Hayon YaelVP, Research & Development | Award | 35,115 | — | Form 4 |
| Aug 15, 2023 | Rubin EyalSr. VP and CFO | Award | 201,903 | — | Form 4 |
| Jan 3, 2023 | Schwartz AharonDirector | Buy | 110,000 | $155.81K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4